304 related articles for article (PubMed ID: 27644951)
21. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
McHugh KE; Policarpio-Nicolas MLC
Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
[TBL] [Abstract][Full Text] [Related]
22. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract][Full Text] [Related]
23. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
[TBL] [Abstract][Full Text] [Related]
24. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract][Full Text] [Related]
25. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns.
Franchi A; Moroni M; Massi D; Paglierani M; Santucci M
Am J Surg Pathol; 2002 Dec; 26(12):1597-604. PubMed ID: 12459626
[TBL] [Abstract][Full Text] [Related]
26. Newly Described Tumor Entities in Sinonasal Tract Pathology.
Bishop JA
Head Neck Pathol; 2016 Mar; 10(1):23-31. PubMed ID: 26830406
[TBL] [Abstract][Full Text] [Related]
27. [SMARCB1 (INI1)-deficient sinonasal carcinoma: a clinicopathological analysis of six cases].
Tang SJ; Zhai CW; Yuan CC; Zhang JH; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):47-51. PubMed ID: 31914534
[No Abstract] [Full Text] [Related]
28. Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.
Dogan S; Cotzia P; Ptashkin RN; Nanjangud GJ; Xu B; Momeni Boroujeni A; Cohen MA; Pfister DG; Prasad ML; Antonescu CR; Chen Y; Gounder MM
Hum Pathol; 2020 Oct; 104():105-116. PubMed ID: 32818509
[TBL] [Abstract][Full Text] [Related]
29. SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
Fuoco J; Huang M; Esfandiari N; MacMillan C; Ali A; Dave K; Freilich M; Magalhaes M
Head Neck; 2024 Mar; 46(3):E32-E39. PubMed ID: 38088461
[TBL] [Abstract][Full Text] [Related]
30. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
Ramalingam P; Croce S; McCluggage WG
Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
[TBL] [Abstract][Full Text] [Related]
31. Loss of
Chitguppi C; Rabinowitz MR; Johnson J; Bar-Ad V; Fastenberg JH; Molligan J; Berman E; Nyquist GG; Rosen MR; Evans JE; Mardekian SK
J Neurol Surg B Skull Base; 2020 Dec; 81(6):610-619. PubMed ID: 33381364
[No Abstract] [Full Text] [Related]
32. [Sinonasal tumors : News from the WHO with special reference to mesenchymal entities].
Agaimy A; Haller F; Hartmann A
Pathologe; 2018 Feb; 39(1):18-26. PubMed ID: 29396607
[TBL] [Abstract][Full Text] [Related]
33. SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review.
Ng JKM; Chan JYK; Li JJX; Tang K; Yeung DCM; Chan ABW
Head Neck Pathol; 2022 Sep; 16(3):934-941. PubMed ID: 35257325
[TBL] [Abstract][Full Text] [Related]
34. Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case.
Gonçalves JM; Scarini JF; Gondak R; Altemani A; Mariano FV
Oral Oncol; 2022 Mar; 126():105779. PubMed ID: 35183913
[TBL] [Abstract][Full Text] [Related]
35. SWI/SNF-deficient Sinonasal Carcinomas.
Agaimy A
Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
[TBL] [Abstract][Full Text] [Related]
36. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities.
Jeng YM; Sung MT; Fang CL; Huang HY; Mao TL; Cheng W; Hsiao CH
Am J Surg Pathol; 2002 Mar; 26(3):371-6. PubMed ID: 11859210
[TBL] [Abstract][Full Text] [Related]
37. High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling.
Guilmette J; Sadow PM
Arch Pathol Lab Med; 2019 Nov; 143(11):1416-1419. PubMed ID: 30779592
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic algorithm for challenging blue cell sinonasal carcinoma.
Laforga JB; Abdullah B
Pathol Res Pract; 2023 Aug; 248():154683. PubMed ID: 37478521
[TBL] [Abstract][Full Text] [Related]
39. SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.
Trieu V; Aulet RM; Ciolino A; Rimash T
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):676-680. PubMed ID: 30873845
[TBL] [Abstract][Full Text] [Related]
40. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
Kezlarian BE; Lin O; Dogan S
J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]